E-LIB Suche - Ergebnisse für: Warren, R B

1

LB946 Spesolimab controls chronic inflammation in GPP:

Krueger, J.G. ; Gudjonsson, J.E. ; Morita, A....
Journal of Investigative Dermatology. 144 (2024) 8 - p. S165 , 2024

Link: https://doi.org/10.1016/..

2

Tolérance à long terme du bimékizumab chez les patients att..:

Breban, M. ; Mease, P.J. ; Poddubnyy, D....
Revue du Rhumatisme. 90 (2023) - p. A188-A189 , 2023

Link: https://doi.org/10.1016/..

3

MSR85 Psoriasis Symptoms and Impacts Measure: Identifying K..:

Warren, R.B. ; Augustin, M. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S409 , 2023

Link: https://doi.org/10.1016/..

4

CO10 A Matching-Adjusted Indirect Comparison of the Efficac..:

Mease, P.J. ; Warren, R.B. ; Nash, P....
Value in Health. 26 (2023) 12 - p. S16 , 2023

Link: https://doi.org/10.1016/..

5

Drug survival and safety of biosimilars and originator adal..:

Phan, Duc Binh ; Jourdain, Hugo ; González-Quesada, Alicia...
BMJ Open. 13 (2023) 7 - p. e075197 , 2023

Link: https://doi.org/10.1136/..

6

MSR52 Defining Severity Category Thresholds to Guide Psoria..:

Augustin, M. ; Gottlieb, A.B. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S402-S403 , 2023

Link: https://doi.org/10.1016/..

7

PCR234 Impact of Draining Tunnels on Patient- and Physician..:

Kirby, J. ; Hamzavi, I. ; Villani, A.P....
Value in Health. 26 (2023) 6 - p. S356 , 2023

Link: https://doi.org/10.1016/..

8

Secukinumab improves the quality‐of‐life of family members ..:

Finlay, A. Y. ; Barker, J. N. ; Burden, A. D....
JEADV Clinical Practice. 1 (2022) 3 - p. 207-218 , 2022

Link: https://doi.org/10.1002/..

9

Long‐term efficacy and safety of brodalumab in moderate‐to‐..:

Reich, K. ; Iversen, L. ; Puig, L....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 8 - p. 1275-1283 , 2022

Link: https://doi.org/10.1111/..

10

Le bimékizumab chez des patients atteints de rhumatisme pso..:

Gossec, L. ; McInnes, I.B. ; Coates, L.C....
Revue du Rhumatisme. 89 (2022) - p. A74-A75 , 2022

Link: https://doi.org/10.1016/..

11

Long‐term, durable, absolute Psoriasis Area and Severity In..:

Gooderham, M. ; Pinter, A. ; Ferris, L.K....
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 6 - p. 855-865 , 2022

Link: https://doi.org/10.1111/..

12

Le bimékizumab chez des patients atteints de rhumatisme pso..:

Gossec, L. ; Merola, J.F. ; McInnes, I.B....
Revue du Rhumatisme. 89 (2022) - p. A76-A77 , 2022

Link: https://doi.org/10.1016/..

13

Five‐year efficacy and safety of tildrakizumab in patients ..:

Thaci, D. ; Piaserico, S. ; Warren, R.B....
British Journal of Dermatology. 185 (2021) 2 - p. 323-334 , 2021

Link: https://doi.org/10.1111/..

14

Editorial: fixed‐dose combination calcipotriol/betamethason..:

Lebwohl, M. ; Warren, R.B.
Journal of the European Academy of Dermatology and Venereology. 35 (2021) S1 - p. 3-4 , 2021

Link: https://doi.org/10.1111/..

15

Network meta‐analysis of biologic treatments for psoriasis ..:

Mrowietz, U. ; Warren, R.B. ; Leonardi, C.L....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 5 - p. 1161-1175 , 2021

Link: https://doi.org/10.1111/..